167 related articles for article (PubMed ID: 6195981)
1. Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solutions.
Saunders CR; Carlisle L; Bick RL
Ann Thorac Surg; 1983 Nov; 36(5):532-9. PubMed ID: 6195981
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery.
Kuitunen AH; Hynynen MJ; Vahtera E; Salmenperä MT
Anesth Analg; 2004 Feb; 98(2):291-297. PubMed ID: 14742357
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass.
Tigchelaar I; Gallandat Huet RC; Korsten J; Boonstra PW; van Oeveren W
Eur J Cardiothorac Surg; 1997 Apr; 11(4):626-32. PubMed ID: 9151028
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting.
Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628
[TBL] [Abstract][Full Text] [Related]
7. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.
Vogt NH; Bothner U; Lerch G; Lindner KH; Georgieff M
Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
[TBL] [Abstract][Full Text] [Related]
9. Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial.
Svendsen ØS; Farstad M; Mongstad A; Haaverstad R; Husby P; Kvalheim VL
Perfusion; 2018 Sep; 33(6):483-489. PubMed ID: 29199540
[TBL] [Abstract][Full Text] [Related]
10. Volume replacement with hydroxyethyl starch solution in children.
Boldt J; Knothe C; Schindler E; Hammermann H; Dapper F; Hempelmann G
Br J Anaesth; 1993 Jun; 70(6):661-5. PubMed ID: 7687142
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
[TBL] [Abstract][Full Text] [Related]
12. Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery.
Miao N; Yang J; Du Z; Liu W; Ni H; Xing J; Yang X; Xu B; Hou X
Perfusion; 2014 Sep; 29(5):462-8. PubMed ID: 24658707
[TBL] [Abstract][Full Text] [Related]
13. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass.
Boldt J; Knothe C; Zickmann B; Andres P; Dapper F; Hempelmann G
Anesth Analg; 1993 Jun; 76(6):1185-90. PubMed ID: 7684579
[TBL] [Abstract][Full Text] [Related]
14. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?
Eising GP; Niemeyer M; Günther T; Tassani P; Pfauder M; Schad H; Lange R
Eur J Cardiothorac Surg; 2001 Aug; 20(2):282-9. PubMed ID: 11463545
[TBL] [Abstract][Full Text] [Related]
15. Influence of different volume therapies on platelet function in the critically ill.
Boldt J; Müller M; Heesen M; Heyn O; Hempelmann G
Intensive Care Med; 1996 Oct; 22(10):1075-81. PubMed ID: 8923073
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.
Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R
Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization.
Kirklin JK; Lell WA; Kouchoukos NT
Ann Thorac Surg; 1984 Jan; 37(1):40-6. PubMed ID: 6197944
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery.
Munsch CM; MacIntyre E; Machin SJ; Mackie IJ; Treasure T
Br J Surg; 1988 Jul; 75(7):675-8. PubMed ID: 2458159
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study.
Gurbuz HA; Durukan AB; Salman N; Tavlasoglu M; Durukan E; Ucar Hİ; Yorgancioglu C
J Cardiothorac Surg; 2013 Apr; 8():71. PubMed ID: 23566712
[TBL] [Abstract][Full Text] [Related]
20. Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement.
Omar MN; Shouk TA; Khaleq MA
Clin Biochem; 1999 Jun; 32(4):269-74. PubMed ID: 10463819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
